NCT02522208View on ClinicalTrials.gov

Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Heart Failure
Interventions
DRUG

BiDil XR

fixed combination capsule

DRUG

BiDil Immediate Release (IR)

fixed combination tablet

Trial Locations (5)

30310

Morehouse School of Medicine, Atlanta

32216

Jacksonville Center for Clinical Research, Jacksonville

33134

Linfritz Research Institue Inc, Coral Gables

36207

Pinnacle Research Group, LLC, Anniston

02908

Center for Medical Research, LLC, Providence

Sponsors
All Listed Sponsors
lead

Arbor Pharmaceuticals, Inc.

INDUSTRY

NCT02522208 - Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets | Biotech Hunter | Biotech Hunter